CellSource Co (TSE:4880) Ending Cash Position: 円4,787 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4880 CellSource Co Ltd TSE:4880
69 GF Score
Price 円341.00
GF Value 円776.63
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is CellSource Co Ending Cash Position?

CellSource Co TSE:4880 -0.58% 69 Ending Cash Position is 円4,787 Mil as of Apr. 2026. GuruFocus rates TSE:4880 with a GF Score™ of 69/100 and a GF Value™ of 円776.63 (Significantly Undervalued). The stock has 6 warning signs investors should review.

CellSource Co's Ending Cash Position for the quarter that ended in Apr. 2026 was 円4,787 Mil.

CellSource Co's quarterly Ending Cash Position increased from Apr. 2025 (円4,408 Mil) to Oct. 2025 (円4,712 Mil) and increased from Oct. 2025 (円4,712 Mil) to Apr. 2026 (円4,787 Mil).

CellSource Co's annual Ending Cash Position declined from Oct. 2023 (円4,781 Mil) to Oct. 2024 (円4,321 Mil) but then increased from Oct. 2024 (円4,321 Mil) to Oct. 2025 (円4,712 Mil).

CellSource Co Ending Cash Position Related Terms

CellSource Co Ending Cash Position Historical Data

* Premium members only.

The historical data trend for CellSource Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellSource Co Ending Cash Position Chart

CellSource Co Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 2,409.32 3,123.58 4,781.02 4,320.92 4,711.82

CellSource Co Semi-Annual Data
Oct17 Oct18 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23 Apr24 Oct24 Apr25 Oct25 Apr26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,598.90 -277.98 4,407.92 4,711.82 4,786.53
TSE:4880
69GF Score
CellSource Co Ltd TSE:4880
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CellSource Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

CellSource Co's Ending Cash Position for the fiscal year that ended in Oct. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=4320.916+390.904
=4,712

CellSource Co's Ending Cash Position for the quarter that ended in Apr. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=4711.82+74.711
=4,787

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of 円4,787 Mil mean?
CellSource Co (TSE:4880) has a Ending Cash Position of 円4,787 Mil as of Apr. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on CellSource Co and its competitors.
Is CellSource Co's Ending Cash Position too high?
CellSource Co's current Ending Cash Position is 円4,787 Mil. Overall, CellSource Co has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CellSource Co's Ending Cash Position compare to VRTX and REGN?
CellSource Co's Ending Cash Position of 円4,787 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on CellSource Co and its competitors. CellSource Co's current Ending Cash Position is 円4,787 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellSource Co stock overvalued right now?
Based on GuruFocus' analysis, CellSource Co (TSE:4880) is currently considered Significantly Undervalued. The stock's GF Value™ is 円776.63, compared to a current price of 円341.00 — trading 56.1% below its estimated fair value. The current Ending Cash Position is 円4,787 Mil. CellSource Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For CellSource Co (TSE:4880), the current Ending Cash Position is 円4,787 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CellSource Co (TSE:4880) Overvalued in 2026?

Based on GuruFocus' analysis, CellSource Co stock appears to be undervalued. The current stock price of 円341.00 is trading 56.1% below its estimated GF Value™ of 円776.63. GuruFocus considers CellSource Co to be Significantly Undervalued.

Key valuation signals for TSE:4880:

  • Ending Cash Position: 円4,787 Mil
  • GF Value™: 円776.63 vs. price of 円341.00 (56.1% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the TSE:4880 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CellSource Co Business Description

Address Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.
69GF Score

Get the complete analysis for TSE:4880

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円341.00
Price
円776.63
GF Value